Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aliud pharma gmbh (3270510) - ambrisentan - filmtablette - 10 mg - teil 1 - filmtablette; ambrisentan (30792) 10 milligramm

Šveits - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - ambrisentanum - filmtabletten - filmtablette: ambrisentanum 5 mg, cellulosum microcristallinum, lactosum monohydricum 47.5 mg, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 129 0.022 mg, lecithinum ex soja, pro compresso obducto corresp. natrium 0.339 mg. - pulmonale arterielle hypertonie - synthetika

Šveits - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - ambrisentanum - filmtabletten - filmtablette: ambrisentanum 10 mg, cellulosum microcristallinum, lactosum monohydricum 95 mg, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 129 0.405 mg, lecithinum ex soja, pro compresso obducto corresp. natrium 0.71 mg. - pulmonale arterielle hypertonie - synthetika

Šveits - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - ambrisentanum - filmtabletten - ambrisentanum 5 mg, lactosum monohydricum 95 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.35 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, e 171, e 129 0.105 mg, pro compresso obducto. - pulmonale arterielle hypertonie - synthetika

Šveits - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - ambrisentanum - filmtabletten - ambrisentanum 10 mg, lactosum monohydricum 90 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.35 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, e 171, e 129 0.4487 mg, pro compresso obducto. - pulmonale arterielle hypertonie - synthetika

Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

1 a pharma gmbh (8013083) - ambrisentan - filmtablette - teil 1 - filmtablette; ambrisentan (30792) 10 milligramm

Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

1 a pharma gmbh (8013083) - ambrisentan - filmtablette - teil 1 - filmtablette; ambrisentan (30792) 5 milligramm

Euroopa Liit - saksa - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - bluthochdruck, lungen - antihypertensiva, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

bluefish pharmaceuticals ab (publ) (8093076) - filmtablette - 10 mg

Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

bluefish pharmaceuticals ab (publ) (8093076) - filmtablette - 5 mg